Neurocrine Biosciences, Inc. (NBIX) is listed on NASDAQ in Biotech Stocks. It is $153.99, -1.24%, with a $15.7B market cap. RSI is 40.2, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 40.2 Neutral
Market Cap $15.7B
Volume 657.7K
Fundamentals — 10-Q Q2 2026
Revenue $1.8B
Net Income $342.3M
EPS $3.30
Operating Margin 19.4%
Net Margin 19.3%
P/E Ratio 46.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Norwalk Leslie V | Director | Sell | 1,250 | $182.01 | $227,508 | 2026 Jul 28 |
| Delaet Ingrid | Chief Regulatory Officer | Sell | 4,367 | $181.02 | $790,514 | 2026 Jul 10 |
| Lippoldt Darin | Chief Legal Officer | Sell | 10,000 | $179.60 | $1.8M | 2026 Jul 9 |
| Delaet Ingrid | Chief Regulatory Officer | Sell | 14,571 | $178.65 | $2.6M | 2026 Jul 9 |
| Lippoldt Darin | Chief Legal Officer | Sell | 10,000 | $170.15 | $1.7M | 2026 Jun 29 |
| Sherwin Stephen A | Director | Sell | 25,000 | $165.32 | $4.1M | 2026 Jun 5 |
| Norwalk Leslie V | Director | Sell | 1,250 | $168.06 | $210,072 | 2026 Jun 4 |
| Cooke Julie | Chief Human Resources Officer | Sell | 36,937 | $156.22 | $5.8M | 2026 Jun 2 |
| Onyia Jude | Chief Scientific Officer | Sell | 11,000 | $160.25 | $1.8M | 2026 Jun 1 |
| Delaet Ingrid | Chief Regulatory Officer | Sell | 2,261 | $156.71 | $354,321 | 2026 May 29 |
| Onyia Jude | Chief Scientific Officer | Sell | 11,000 | $155.53 | $1.7M | 2026 May 27 |
| Boyer David W. | Chief Corp. Affairs Officer | Sell | 3,888 | $156.64 | $609,023 | 2026 May 26 |
| Gorman Kevin Charles | Director | Sell | 245,088 | $154.33 | $37.8M | 2026 May 19 |
| Pops Richard F | Director | Sell | 15,000 | $157.65 | $2.4M | 2026 May 15 |
| Norwalk Leslie V | Director | Sell | 3,810 | $155.01 | $590,601 | 2026 May 12 |
| Norwalk Leslie V | Director | Sell | 6,190 | $152.78 | $945,707 | 2025 Dec 16 |
| Lippoldt Darin | Chief Legal Officer | Sell | 4,376 | $159.65 | $698,628 | 2025 Dec 8 |
| Lyons Gary A | Director | Sell | 15,000 | $152.61 | $2.3M | 2025 Dec 3 |
| Benevich Eric | Chief Commercial Officer | Sell | 5,970 | $151.74 | $905,888 | 2025 Nov 28 |
| Morrow George J | Director | Sell | 15,000 | $143.37 | $2.2M | 2025 Nov 25 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $218.46 | 60.5 | $32.3B |
| | $72.36 | 58.5 | $11.3B |
| | $176.24 | 62.2 | $9.9B |
| | $105.31 | 69.1 | $12.0B |
| | $8.05 | 54.2 | $8.5B |
Take NBIX further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NBIX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Neurocrine Biosciences, Inc. next reports.
Set alerts on NBIX
Get notified when Neurocrine Biosciences, Inc. hits your price targets or technical conditions are met.
Get Started Free